EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Formulation of Gamma-Oryzanol Encapsulated Nanoparticles and Their Modulation Effects on Inducible Nitric Oxide Synthase and Nitric Oxide in LPS-Stimulated RAW 264.7 Macrophages

Kornvipa Settakorn iD, Chuda Chittasupho iD, Weerasak Samee iD, Nut Koonrungsesomboon, Mingkwan Na Takuathung iD

Pharmaceutics · 14.03.2026 · 18 (3) · 365

DOI: 10.3390/pharmaceutics18030365 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 14.03.2026. Verfasst von Kornvipa Settakorn und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Fund 2024, Chiang Mai University, Fundamental Fund 2026, Chiang Mai University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Gamma-oryzanol (ORZ), a bioactive compound extracted from rice bran oil, has health-promoting properties but limited therapeutic use due to poor stability and bioavailability. This study aimed to synthesize gamma-oryzanol-encapsulated nanoparticles (ORZ-NPs) and investigate their anti-inflammatory effects in lipopolysaccharide-stimulated RAW 264.7 macrophages.

Methods

ORZ-NPs were synthesized via nanoprecipitation and characterized by dynamic light scattering and transmission electron microscopy. ORZ content was assessed using high performance liquid chromatography. In vitro release was determined using a dialysis method. Inducible nitric oxide synthase (iNOS) was assessed by Western blotting, nitric oxide (NO) by Griess assay, and tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) by enzyme-linked immunosorbent assay.

Results

ORZ-NPs exhibited spherical morphology with a mean particle size of 93.320 ± 2.027 nm, polydispersity index 0.149 ± 0.025, and zeta potential −22.400 ± 0.252 mV. ORZ remained stable for 90 days. In vitro release reached 70% at 24 h in PBS (pH 7.4). At 50 μg mL−1, ORZ-NPs significantly decreased iNOS and NO production (approximately 65% of control, p < 0.01), without affecting TNF-α or IL-6.

Conclusions

ORZ-NPs demonstrate selective anti-inflammatory activities by suppressing iNOS and NO production while pro-inflammatory cytokines remain unaffected. These findings suggest a partial modulatory effect on the inflammatory signaling pathway.

Schlagwörter

Stichwörter der Autor:innen

RAW 264.7 macrophage cellsgamma-oryzanolinducible nitric oxide synthaseinflammationnanoparticlesnitric oxide

Autor:innen und Institutionen

  • Department of Pharmacology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Clinical Research Center for Food and Herbal Product Trials and Development (CR-FAH), Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Srinakharinwirot University, Nakhon Nayok 26120, Thailand.

ORCID-Profile: Kornvipa Settakorn, Chuda Chittasupho, Weerasak Samee, Mingkwan Na Takuathung

Förderung

  • Fundamental Fund 2024, Chiang Mai University
  • Fundamental Fund 2026
  • Chiang Mai University
  • Thailand Science Research and Innovation

Zitieren

APA

Settakorn, K., Chittasupho, C., Samee, W., Koonrungsesomboon, N., & Takuathung, M. N. (2026). Formulation of Gamma-Oryzanol Encapsulated Nanoparticles and Their Modulation Effects on Inducible Nitric Oxide Synthase and Nitric Oxide in LPS-Stimulated RAW 264.7 Macrophages. Pharmaceutics, 18(3), 365. https://doi.org/10.3390/pharmaceutics18030365

Vancouver

Settakorn K, Chittasupho C, Samee W, Koonrungsesomboon N, Takuathung MN. Formulation of Gamma-Oryzanol Encapsulated Nanoparticles and Their Modulation Effects on Inducible Nitric Oxide Synthase and Nitric Oxide in LPS-Stimulated RAW 264.7 Macrophages. Pharmaceutics. 2026;18(3):365. doi:10.3390/pharmaceutics18030365

BibTeX
@article{Settakorn2026,
  author = {Settakorn, Kornvipa and Chittasupho, Chuda and Samee, Weerasak and Koonrungsesomboon, Nut and Takuathung, Mingkwan Na},
  title = {Formulation of Gamma-Oryzanol Encapsulated Nanoparticles and Their Modulation Effects on Inducible Nitric Oxide Synthase and Nitric Oxide in LPS-Stimulated RAW 264.7 Macrophages},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {3},
  pages = {365},
  doi = {10.3390/pharmaceutics18030365}
}
Kostenlos starten →